Transjugular Portosystemic Shunting in Refractory Cirrhotic Ascites

Aim. Improvement of refractory ascites (RA) outcomes in underlying cirrhotic portal hypertension (PH) through optimising the transjugular intrahepatic portosystemic shunting (TIPS) procedure among therapy measures.Materials and methods. The survey included 107 patients with RA admitted to portal hyp...

Full description

Saved in:
Bibliographic Details
Main Authors: Yu. V. Khoronko, M. A. Kozyrevskiy, A. V. Dmitriev, A. A. Volokhova, G. Yu. Spiridenko, K. R. Bogomolova
Format: Article
Language:Russian
Published: Gastro LLC 2021-04-01
Series:Российский журнал гастроэнтерологии, гепатологии, колопроктологии
Subjects:
Online Access:https://www.gastro-j.ru/jour/article/view/542
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1823860140974014464
author Yu. V. Khoronko
M. A. Kozyrevskiy
A. V. Dmitriev
A. A. Volokhova
G. Yu. Spiridenko
K. R. Bogomolova
author_facet Yu. V. Khoronko
M. A. Kozyrevskiy
A. V. Dmitriev
A. A. Volokhova
G. Yu. Spiridenko
K. R. Bogomolova
author_sort Yu. V. Khoronko
collection DOAJ
description Aim. Improvement of refractory ascites (RA) outcomes in underlying cirrhotic portal hypertension (PH) through optimising the transjugular intrahepatic portosystemic shunting (TIPS) procedure among therapy measures.Materials and methods. The survey included 107 patients with RA admitted to portal hypertension units of the Rostov State Medical University Surgical Clinic during 2007—2020. The patients were randomly assigned to two cohorts similar by gender, age, cirrhosis aetiology and condition severity. The control cohort had conventional paracentesis and albumin infusion. In cohort 2, 57 patients had minimally invasive endovascular TIPS surgery in a recommended setting.Results. TIPS eliminated PH in all 57 patients of cohort 2. Cohort 1 was reported with progressive esophagogastric varices (EGV), their enlargement in 37 and rupture in 11 patients during the first 12 months. Cohort 2 revealed the grade 3—2 and 2—1 EGV reduction in 24 (41.1%) patients with shunt surgery and in 39 (68.4%) patients in one year. Esophagogastric variceal bleeding (EGVB) developed in 9 patients in cohort 1, with 7 lethal outcomes. No variceal bleeding was observed in cohort 2, with 7 patients having the portosystemic shunt dysfunction.Conclusion. The TIPS procedure is justified in cirrhotic PH patients with RA for reducing the mortality rate in a one year follow-up.
format Article
id doaj-art-89cdcb7305294e8d8f2945411c411bd5
institution Kabale University
issn 1382-4376
2658-6673
language Russian
publishDate 2021-04-01
publisher Gastro LLC
record_format Article
series Российский журнал гастроэнтерологии, гепатологии, колопроктологии
spelling doaj-art-89cdcb7305294e8d8f2945411c411bd52025-02-10T16:14:36ZrusGastro LLCРоссийский журнал гастроэнтерологии, гепатологии, колопроктологии1382-43762658-66732021-04-01311394610.22416/1382-4376-2021-31-1-39-46415Transjugular Portosystemic Shunting in Refractory Cirrhotic AscitesYu. V. Khoronko0M. A. Kozyrevskiy1A. V. Dmitriev2A. A. Volokhova3G. Yu. Spiridenko4K. R. Bogomolova5Rostov State Medical UniversityRostov State Medical UniversityRostov State Medical UniversityRostov State Medical UniversityRostov State Medical UniversityRostov State Medical UniversityAim. Improvement of refractory ascites (RA) outcomes in underlying cirrhotic portal hypertension (PH) through optimising the transjugular intrahepatic portosystemic shunting (TIPS) procedure among therapy measures.Materials and methods. The survey included 107 patients with RA admitted to portal hypertension units of the Rostov State Medical University Surgical Clinic during 2007—2020. The patients were randomly assigned to two cohorts similar by gender, age, cirrhosis aetiology and condition severity. The control cohort had conventional paracentesis and albumin infusion. In cohort 2, 57 patients had minimally invasive endovascular TIPS surgery in a recommended setting.Results. TIPS eliminated PH in all 57 patients of cohort 2. Cohort 1 was reported with progressive esophagogastric varices (EGV), their enlargement in 37 and rupture in 11 patients during the first 12 months. Cohort 2 revealed the grade 3—2 and 2—1 EGV reduction in 24 (41.1%) patients with shunt surgery and in 39 (68.4%) patients in one year. Esophagogastric variceal bleeding (EGVB) developed in 9 patients in cohort 1, with 7 lethal outcomes. No variceal bleeding was observed in cohort 2, with 7 patients having the portosystemic shunt dysfunction.Conclusion. The TIPS procedure is justified in cirrhotic PH patients with RA for reducing the mortality rate in a one year follow-up.https://www.gastro-j.ru/jour/article/view/542portal hypertensiontipsrefractory ascitesliver cirrhosisesophagogastric varicesbleedinghepatorenal syndrome
spellingShingle Yu. V. Khoronko
M. A. Kozyrevskiy
A. V. Dmitriev
A. A. Volokhova
G. Yu. Spiridenko
K. R. Bogomolova
Transjugular Portosystemic Shunting in Refractory Cirrhotic Ascites
Российский журнал гастроэнтерологии, гепатологии, колопроктологии
portal hypertension
tips
refractory ascites
liver cirrhosis
esophagogastric varices
bleeding
hepatorenal syndrome
title Transjugular Portosystemic Shunting in Refractory Cirrhotic Ascites
title_full Transjugular Portosystemic Shunting in Refractory Cirrhotic Ascites
title_fullStr Transjugular Portosystemic Shunting in Refractory Cirrhotic Ascites
title_full_unstemmed Transjugular Portosystemic Shunting in Refractory Cirrhotic Ascites
title_short Transjugular Portosystemic Shunting in Refractory Cirrhotic Ascites
title_sort transjugular portosystemic shunting in refractory cirrhotic ascites
topic portal hypertension
tips
refractory ascites
liver cirrhosis
esophagogastric varices
bleeding
hepatorenal syndrome
url https://www.gastro-j.ru/jour/article/view/542
work_keys_str_mv AT yuvkhoronko transjugularportosystemicshuntinginrefractorycirrhoticascites
AT makozyrevskiy transjugularportosystemicshuntinginrefractorycirrhoticascites
AT avdmitriev transjugularportosystemicshuntinginrefractorycirrhoticascites
AT aavolokhova transjugularportosystemicshuntinginrefractorycirrhoticascites
AT gyuspiridenko transjugularportosystemicshuntinginrefractorycirrhoticascites
AT krbogomolova transjugularportosystemicshuntinginrefractorycirrhoticascites